In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Boston Life Sciences takes steps to further Its focus on neurology
Drug delivery device supply agreement for Boston Life Sciences and Codman & Shurtleff
Boston Life Sciences announces identification of Troponin I analogue
ZymoGenetics Licenses Non-Core Assets to Seattle Life Sciences
Neurogen signs AIDD license agreement with Pfizer
Human Genome Sciences license agreement with Pfizer
OXFORD BIOMEDICA SIGNS LENTIVECTOR® LICENSING AGREEMENT WITH PFIZER